Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris, France. It manages over €31 billion in assets across corporate and secondary private equity, multi-manager funds, co-investments, and…Read full bio
5 funds tracked, 53 portfolio companies (32 active · 21 realized). Verified weekly from public filings and deal announcements.
Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris with €31 billion of assets under management across corporate and secondary private equity, multi-manager funds, co-investments and credit strategies. The platform leverages the multi-century Rothschild banking heritage to provide diversified alternative asset management across multiple distinct strategy categories.
Five Arrows deploys capital across complementary alternative strategies including corporate private equity (mid-market buyout and growth), secondary private equity (LP-led and GP-led secondary transactions), multi-manager funds (fund-of-funds positions), co-investments alongside lead sponsors, and credit strategies (private debt and credit secondaries). The multi-strategy mandate enables Five Arrows to provide institutional limited partners with diversified European alternative asset exposure.
Recent realised exits include Softway Medical (healthcare, 2025), Harvest (financials, 2024) and Menix Group (healthcare, 2024), reflecting strong distribution across the multi-strategy alternative platform. The platform tracks 3 funds tracked on GP Intel, 32 active portfolio companies and 21 realised exits across the broader Five Arrows alternative asset programme. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in